Avalo Therapeutics (AVTX) Insider Trading & Ownership $5.04 0.00 (0.00%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$5.22 +0.19 (+3.67%) As of 05/2/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics (NASDAQ:AVTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.25%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$6,250.00Number OfInsiders Selling(Last 12 Months)0 Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVTX Insider Buying and Selling by Quarter Avalo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/12/2024June Sherie AlmenoffDirectorBuy500$12.50$6,250.00 (Data available from 1/1/2013 forward) AVTX Insider Trading Activity - Frequently Asked Questions Who is on Avalo Therapeutics's Insider Roster? The list of insiders at Avalo Therapeutics includes Armistice Capital, Llc, Caissa Capital Management Ltd., Christopher Ryan Sullivan, Garry Arthur Neil, and June Sherie Almenoff. Learn more on insiders at AVTX. What percentage of Avalo Therapeutics stock is owned by insiders? 0.25% of Avalo Therapeutics stock is owned by insiders. Learn more on AVTX's insider holdings. Which Avalo Therapeutics insiders have been buying company stock? The following insiders have purchased AVTX shares in the last 24 months: Caissa Capital Management Ltd. ($184,641.60), Christopher Ryan Sullivan ($1,641.60), Garry Arthur Neil ($13,132.80), and June Sherie Almenoff ($6,250.00). How much insider buying is happening at Avalo Therapeutics? Insiders have purchased a total of 762 AVTX shares in the last 24 months for a total of $205,666.00 bought. Which Avalo Therapeutics insiders have been selling company stock? The following insider sold AVTX shares in the last 24 months: Armistice Capital, Llc ($1,675,108.80). How much insider selling is happening at Avalo Therapeutics? Insiders have sold a total of 11,442 Avalo Therapeutics shares in the last 24 months for a total of $1,675,108.80 sold. Avalo Therapeutics Key ExecutivesDr. Garry A. Neil M.D. (Age 70)Chairman of the Board, President & CEO Compensation: $475kMr. Christopher Ryan Sullivan (Age 40)CFO & Head of Investor relations Compensation: $350kDr. Solomon H. Snyder M.D. (Age 85)Founder and Chairman of Scientific Advisory Board Dr. Barbara S. Slusher Ph.D. (Age 59)Founder and Member of Scientific Advisory Board Dr. Lisa Hegg Ph.D.Senior Vice President of Program Management, Corporate Infrastructure & Clinical OperationsMs. Colleen MatkowskiSenior Vice President of Global Regulatory Affairs & Quality AssuranceDr. Dino C. Miano Ph.D.Senior Vice President of CMC & Technical Operations More Insider Trading Tools from MarketBeat Related Companies GOSS Insider Ownership DMAC Insider Ownership CRDF Insider Ownership VYGR Insider Ownership ALMS Insider Ownership FULC Insider Ownership BTMD Insider Ownership INMB Insider Ownership ESPR Insider Ownership INBX Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles McDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why This page (NASDAQ:AVTX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMassive red flag about American consumerWhy is the U.S. Dollar suddenly crashing? Pundits on either side of the aisle have been warning that the U....Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
